An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases
Clinical trial NCT06093698 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06093698
- Sponsor
- ITabMed Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-06-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.